Gsk (GSK) Goodwill (2009 - 2026)
Gsk (GSK) posted Goodwill of $9.3 billion for Q4 2025, up 4.17% on a QoQ basis from $9.0 billion in Q4 2024, and up 4.17% year-over-year from $9.0 billion in Q4 2024.
Gsk (GSK) has 11 years of Goodwill data on file, last reported at $9.3 billion in Q4 2025.
- In Q4 2025, Goodwill rose 4.17% year-over-year to $9.3 billion; the TTM figure through Dec 2025 stood at $9.3 billion (up 4.17% YoY), while the FY2025 annual figure was $9.3 billion, up 4.17% from the prior year.
- Goodwill grew to $9.3 billion in Q4 2025, from $9.0 billion in the prior quarter.
- Across five years, Goodwill topped out at $14.2 billion in Q4 2021 and bottomed at $8.3 billion in Q4 2022.
- A 5-year average of $9.8 billion and a median of $9.0 billion in 2024 frame the typical range for Goodwill.
- Annual changes were most pronounced in 2022 — Goodwill tumbled 41.9% — and 2024, when it advanced 6.01%.
- Year by year, Goodwill stood at $14.2 billion in 2021, then tumbled by 41.9% to $8.3 billion in 2022, then advanced by 2.29% to $8.5 billion in 2023, then gained by 6.01% to $9.0 billion in 2024, then advanced by 4.17% to $9.3 billion in 2025.
- The last three Goodwill figures came in at $9.3 billion (Q4 2025), $9.0 billion (Q4 2024), and $8.5 billion (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.82 Bn |
| Dec 31, 2025 | 9.34 Bn |
| Sep 30, 2025 | 9.60 Bn |
| Jun 30, 2025 | 8.98 Bn |
| Mar 31, 2025 | 8.72 Bn |
| Dec 31, 2024 | 8.96 Bn |
| Sep 30, 2024 | 8.68 Bn |
| Jun 30, 2024 | 8.79 Bn |
| Mar 31, 2024 | 8.85 Bn |
| Dec 31, 2023 | 8.45 Bn |
| Sep 30, 2023 | 8.83 Bn |
| Jun 30, 2023 | 8.40 Bn |
| Mar 31, 2023 | 8.33 Bn |
| Dec 31, 2022 | 8.26 Bn |
| Sep 30, 2022 | 8.48 Bn |
| Jun 30, 2022 | 7.44 Bn |
| Mar 31, 2022 | 11.11 Bn |
| Dec 31, 2021 | 14.22 Bn |
| Sep 30, 2021 | 14.59 Bn |
| Jun 30, 2021 | 14.59 Bn |
| Mar 31, 2021 | 14.40 Bn |
| Dec 31, 2020 | 13.99 Bn |
| Sep 28, 2020 | 156.99 Mn |
| Jun 30, 2020 | 13.66 Bn |
| Mar 31, 2020 | 13.97 Bn |
| Dec 31, 2019 | 13.58 Bn |
| Sep 30, 2019 | 13.62 Bn |
| Jun 30, 2019 | 9.04 Bn |
| Mar 31, 2019 | 8.86 Bn |
| Dec 31, 2018 | 7.45 Bn |
| Sep 30, 2018 | 7.62 Bn |
| Jun 30, 2018 | 7.87 Bn |
| Mar 31, 2018 | 7.79 Bn |
| Dec 31, 2017 | 7.61 Bn |
| Sep 30, 2017 | 7.54 Bn |
| Jun 30, 2017 | 7.49 Bn |
| Mar 31, 2017 | 7.38 Bn |
| Dec 31, 2016 | 7.42 Bn |
| Sep 30, 2016 | 7.71 Bn |
| Jun 30, 2016 | 8.25 Bn |
| Mar 31, 2016 | 7.73 Bn |
| Dec 31, 2015 | 7.83 Bn |
| Sep 30, 2015 | 8.01 Bn |
| Jun 30, 2015 | 7.76 Bn |
| Mar 31, 2015 | 7.90 Bn |
| Dec 31, 2014 | 5.90 Bn |
| Sep 30, 2014 | 6.24 Bn |
| Jun 30, 2014 | 6.17 Bn |
| Mar 31, 2014 | 6.90 Bn |
| Dec 31, 2013 | 6.81 Bn |
| Sep 30, 2013 | 6.69 Bn |
| Jun 30, 2013 | 6.91 Bn |
| Mar 31, 2013 | 7.07 Bn |
| Dec 31, 2012 | 892.86 Mn |
| Sep 30, 2012 | 6.96 Bn |
| Jun 30, 2012 | 5.89 Bn |
| Mar 31, 2012 | 5.75 Bn |
| Dec 31, 2011 | 913.08 Mn |
| Sep 30, 2011 | 6.03 Bn |
| Jun 30, 2011 | 6.11 Bn |
| Mar 31, 2011 | 5.94 Bn |
| Dec 31, 2010 | 5.70 Bn |
| Sep 30, 2010 | 5.40 Bn |
| Jun 30, 2010 | 5.29 Bn |
| Mar 31, 2010 | 5.50 Bn |
| Dec 31, 2009 | 5.49 Bn |
| Sep 30, 2009 | 5.40 Bn |
| Jun 30, 2009 | 3.12 Bn |
| Mar 31, 2009 | 3.09 Bn |